Skip to content

Cannabis: all studies

Page 9 of 288: studies 81 to 90 of 2,874, newest first. Back to the cannabis overview

Research

Adolescent Δ9-THC Exposure Differentially Affects Mice Depending on Their Personality.

Pharmaceuticals June 29, 2026 Dilorom Begmatova, Liudmila Vinnikova, Natalya Zemliana et al.

Background: Adolescence is a sensitive period for brain maturation during which exposure to Δ9-tetrahydrocannabinol (THC) can induce long-lasting neurobehavioral alterations. Yet, preclinical and clinical studies report inconsistent long-term outcomes of adolescent THC exposure, ranging from clear impairments to apparently normalizing effects. We hypothesize that these discrepancies reflect...

Understanding Daily Cannabis Use among Young Adults in Post-Legalization Québec: Motivations, Consumption Practices, and Control Strategies.

Substance Use & Misuse June 27, 2026 I. Janezic, Marie-Ève Levasseur

BACKGROUND In the wake of cannabis legalization in Canada, daily use among young adults remains insufficiently understood. This study explores the motivations, consumption practices, and self-regulation strategies of young adults who use cannabis daily in the region of Capitale-Nationale, Québec. METHODS Forty-six individuals aged 18-34 who consume cannabis daily participated in semi-structured...

Cannabis use and glutamate across the psychosis spectrum: in vivo evidence from 7T proton magnetic resonance spectroscopy

Molecular Psychiatry June 27, 2026 David R. Roalf, Tyler M Moore, Jacquelyn Stifelman et al.

Abstract Cannabis use is linked to elevated psychosis risk, yet the neurobiological mechanisms that couple use to symptom expression remain unclear. Because glutamatergic dysregulation has been implicated in both cannabis effects and psychosis vulnerability, we examined whether brain glutamate relates to dimensional symptoms as a function of cannabis use across the psychosis spectrum....

DOI: 10.1038/s41380-026-03705-1 (opens in new tab) Full text (opens in new tab) Glutamatergic Psychosis Glutamate receptor Effects of cannabis +5

Psychotic-like experiences and neurobehavioral reward processing in adolescents who use cannabis

PsyArXiv Preprints June 25, 2026 preprint

Importance: Cannabis use (CU) in adolescence is linked to increased risk of developing psychotic-like experiences (PLEs) that can lead to lifelong impairment. A candidate mechanism may be disruptions in reward processing supported by dopamine but this association has not yet been tested in adolescents with CU and PLEs. The objective of the study was to assess the interrelation between CU, PLEs,...

Unbecoming a Marijuana User

Qualitative Sociology June 23, 2026 Eduardo Durán

Abstract In this paper, I critically engage with Becker’s seminal work on marijuana consumption, challenging the notion of “becoming” a user as a straightforward process of taste acquisition. Drawing on the personal narratives of 38 current and former marijuana users, I show that “becoming” a marijuana user constitutes a dynamic state of tension rather than a linear trajectory with a terminal...

DOI: 10.1007/s11133-026-09634-3 (opens in new tab) Full text (opens in new tab) Experiential learning Narrative Cross-cultural psychology Taste +7

Prenatal THC exposure disrupts mitochondrial respiratory gene programs and medium spiny neuron maturation trajectories in the nucleus accumbens.

bioRxiv June 19, 2026 Zhong Chen, Wanqiu Chen, Yun Seok Lee et al. preprint

Prenatal cannabis exposure (PCE) is increasingly prevalent and has been associated with adverse neurodevelopmental outcomes, yet its molecular impact on brain reward circuitry remains poorly defined. Here, we investigated transcriptional and epigenomic alterations in the nucleus accumbens (NAc) following prenatal Δ9-tetrahydrocannabinol exposure in a rat model using snRNA-seq and snATAC-seq...

Emergency department use by individuals with and without psychosis after state-level cannabis legalization and commercialization

Nature Mental Health June 19, 2026 A. Hyatt, M. Flores, Lindsay N. Overhage et al.

Recreational cannabis legalization and commercialization are expanding rapidly in the USA, with potential negative effects for individuals with psychotic disorders. Here, to assess potential health risks associated with the opening of cannabis retail outlets, we conducted a longitudinal cohort study using a nationally representative survey to evaluate trends in emergency department utilization...

Cannabis, Psychedelics, and Other Substance Use to Manage Premenstrual Symptoms: A Survey Study.

Journal of Women's Health June 19, 2026 Michelle Nazareth, Victoria Paone, Mary Elizabeth Yaden et al.

Despite increasing interest in the medical use of substances such as cannabis and psychedelics, little is known about their use to manage premenstrual symptoms. This study assessed self-reported use of substances to manage premenstrual mood and physical symptoms, including among those with premenstrual dysphoric disorder (PMDD) and in perimenopause. Inclusion criteria were age 18 and older with...

A Drug Issue, Not A Black Issue?: Cannabis Psychosis and Black People’s Drug Use in Britain, 1982–1992

Social History of Medicine June 18, 2026 Jamie Banks

Abstract During the mid-1980s, British psychiatry erupted into a vehement debate about the disproportionate use of ‘cannabis psychosis’ as a clinical diagnosis amongst young Black men admitted into psychiatric care. Assessing contemporary suggestions that these unequal rates of diagnosis reflected elevated rates of drug use in Black communities more generally, this article uses sources such as...

An Exploration of Heart Rate Response and Blood Tetrahydrocannabinol (THC) Levels to Commercially Available Cannabis Edibles by Dose

Research Square June 11, 2026 Sarah A Limbacher, Sarah Bird, Julia Wrobel et al. preprint

Abstract Introduction: Studies have shown that tetrahydrocannabinol (THC) consumption can acutely increase heart rate (HR) regardless of the percent concentration of the product consumed, mode of consumption (e.g. flower, edibles, concentrate), and tolerance. Prior studies have found that the magnitude of this effect is slightly larger in inhaled products, however few purposeful studies on HR...